Literature DB >> 23685804

Protective effects and active ingredients of yi-qi-fu-mai sterile powder against myocardial oxidative damage in mice.

Yu-Qing Wang1, Chun-Hua Liu, Jie-Qiong Zhang, Dan-Ni Zhu, Bo-Yang Yu.   

Abstract

This study aims to evaluate the protective effects of Yi-Qi-Fu-Mai sterile powder (YQFM) on myocardial oxidative damage and tries to identify the active components responsible for its pharmacological benefits. YQFM and the n-butanol extract of YQFM (YQFM-Bu) were administered to ISO-induced myocardial injury mice. Left ventricle weight index and histopathological analyses were conducted. Serum enzymatic activities of lactate dehydrogenase (LDH), creatine kinase (CK) and superoxide dismutase (SOD), myeloperoxidase (MPO), and the levels of malondialdehyde (MDA) were also measured. Our results demonstrated that both YQFM and YQFM-Bu significantly restored the abnormal activities of CK, LDH, MPO, SOD, and the levels of MDA in ISO-induced myocardial injury mice, and these biochemical results were further supported by histopathological data. Our in vitro findings also confirmed that both YQFM and YQFM-Bu exhibit significant radical scavenging activity. Furthermore, the major active fractions of YQFM were identified by UPLC-MS/MS. Twenty-five ginsenosides and three lignans were identified from YQFM-Bu. These findings suggested YQFM-Bu is the major active fraction of YQFM with the ginsenosides and lignans as potential active components responsible for its protective effect against myocardial injury, and YQFM exerted its beneficial effects on myocardial injury mainly through inhibiting oxidative damage and maintaining the functional integrity of myocardial tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685804     DOI: 10.1254/jphs.12261fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  4 in total

1.  YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis.

Authors:  Guosheng Cao; Huana Zhou; Nan Jiang; Yuwei Han; Yang Hu; Yuanyuan Zhang; Jin Qi; Junping Kou; Boyang Yu
Journal:  Oxid Med Cell Longev       Date:  2016-03-20       Impact factor: 6.543

2.  Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca2+-Calcineurin-Mediated Drp1 Signaling Pathways.

Authors:  Ye Yang; Yushan Tian; Siyao Hu; Suxia Bi; Suxia Li; Yuanjia Hu; Junping Kou; Jin Qi; Boyang Yu
Journal:  Int J Mol Sci       Date:  2017-08-25       Impact factor: 5.923

3.  Rationale and design of the AUGUST-AHF Study.

Authors:  Jingjing Zhang; Yang Sun; Kehua Zhou; Xiaoyu Zhang; Ying Chen; Jiayuan Hu; Changming Zhong; Yan Liu; Hongcai Shang
Journal:  ESC Heart Fail       Date:  2020-06-22

4.  YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.

Authors:  Guosheng Cao; Xinyi Ye; Yingqiong Xu; Mingzhu Yin; Honglin Chen; Junping Kou; Boyang Yu
Journal:  Drug Des Devel Ther       Date:  2016-01-14       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.